Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
FUROSEMIDE
Sanofi-Aventis Ireland Limited
40 Milligram
2002-04-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lasix 40 mg Tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Lasix 40 mg Tablets each contain 40 mg Furosemide. For excipients, see 6.1. 3 PHARMACEUTICAL FORM Tablets. White, round tablets with ‘DLI’ engraved on one face and ‘Hoechst’ on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lasix is used for the management of fluid retention and for the management of mild to moderate hypertension, either alone or as an adjunct. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _General_ The dose used must be the lowest that is sufficient to achieve the desired effect. Lasix has an exceptionally wide therapeutic range, the effect being proportional to the dosage. Lasix is best given as a single dose either daily or on alternate days. The usual initial daily dose is 40 mg. This may require adjustment until the effective dose is achieved as a maintenance dose. In mild cases, 20 mg daily or 40 mg on alternate days may be sufficient, whereas in cases of resistant oedema, daily doses of 80 mg and above may be used as one or two doses daily, or intermittently. Severe cases may require gradual titration of the furosemide dosage up to 600mg daily. The recommended maximum daily dose of furosemide administration is 1500 mg. _Children_ Oral doses for children range from 1 to 3 mg/kg body weight daily up to a maximum total dose of 40 mg/day. _Elderly_ The dosage recommendations for adults apply, but in the elderly furosemide is eliminated more slowly in general. Dosage should be titrated until the required response is achieved. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 24/04/2012_ _CRN 2114728_ _page n Read the complete document